Both in those studies and ours the relationship between circulating NGAL with plasma fasting glucose in T2DM patients before implementation of insulin treatment as well as with HDL cholesterol in patients after a 6-month insulin therapy was found. This evidence concerns the gene LCN2 and type 2 diabetes mellitus.